Orally-administered caspase inhibitor PF-03491390 is retained in the liver for prolonged periods with low systemic exposure, exerting a hepatoprotective effect against alpha-fas-induced liver injury in a mouse model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples